Novo Nordisk's consensus analyst price target has recently been revised downward from DKK 438.59 to DKK 431.99, marking a modest decrease in sentiment. This adjustment comes amid a modest uptick in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback